Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 29, pseudogene (RNU1-29P) is a human gene encoded as a **pseudogene** for U1 small nuclear RNA, a component involved in the spliceosome machinery for pre-mRNA splicing[1][2][3][4]. The canonical U1 snRNA plays a key role in recognizing the 5’ splice site during RNA splicing, but RNU1-29P itself is generally considered a non-functional pseudogene sequence that does not encode a functional RNA or protein product[1][2][3][4]. However, there is emerging evidence that some U1 snRNA pseudogenes—previously considered non-functional—may generate processed transcripts that regulate gene expression at the RNA level in certain contexts, possibly by acting as RNA decoys or modulators of RNA processing[2]. For RNU1-29P specifically, there is **no direct evidence** of functionality and it is not considered a therapeutic target, receptor, enzyme, transporter, or functional gene product[1][2][3][4]. Its main relevance is as a **genomic locus classified as a non-coding RNA pseudogene**.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 29, pseudogene (RNU1-29P).